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Abstract 
Background: Volume‑controlled ventilation has been suggested to optimize lung deposition during nebulization 
although promoting spontaneous ventilation is targeted to avoid ventilator‑induced diaphragmatic dysfunction. 
Comparing topographic aerosol lung deposition during volume‑controlled ventilation and spontaneous ventilation 
in pressure support has never been performed. The aim of this study was to compare lung deposition of a radiola‑
beled aerosol generated with a vibrating‑mesh nebulizer during invasive mechanical ventilation, with two modes: 
pressure support ventilation and volume‑controlled ventilation.
Methods: Seventeen postoperative neurosurgery patients without pulmonary disease were randomly ventilated in 
pressure support or volume‑controlled ventilation. Diethylenetriaminepentaacetic acid labeled with technetium‑99m 
(2 mCi/3 mL) was administrated using a vibrating‑mesh nebulizer (Aerogen Solo®, provided by Aerogen Ltd, Galway, 
Ireland) connected to the endotracheal tube. Pulmonary and extrapulmonary particles deposition was analyzed using 
planar scintigraphy.
Results: Lung deposition was 10.5 ± 3.0 and 15.1 ± 5.0 % of the nominal dose during pressure support and volume‑
controlled ventilation, respectively (p < 0.05). Higher endotracheal tube and tracheal deposition was observed during 
pressure support ventilation (27.4 ± 6.6 vs. 20.7 ± 6.0 %, p < 0.05). A similar penetration index was observed for the 
right (p = 0.210) and the left lung (p = 0.211) with both ventilation modes. A high intersubject variability of lung 
deposition was observed with both modes regarding lung doses, aerosol penetration and distribution between the 
right and the left lung.
Conclusions: In the specific conditions of the study, volume‑controlled ventilation was associated with higher lung 
deposition of nebulized particles as compared to pressure support ventilation. The clinical benefit of this effect war‑
rants further studies.
Clinical trial registration NCT01879488
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Background
Combining aerosol therapy with invasive mechanical ven-
tilation is common in the intensive care unit (ICU) [1].
In vitro and experimental studies have been performed 
to optimize aerosol lung deposition [2, 3]. Many factors 
related to the device, the artificial airways and the respira-
tory pattern inherent to invasive mechanical ventilation 
influence lung deposition [4]. Most of them should be con-
trolled to deliver high doses of concentration-dependent 
drugs such as antibiotics. Vibrating-mesh nebulizers ensure 
currently the best drug output, ergonomy and practical 
use in the ICU [5, 6]. Applying a constant inspiratory flow 
pattern with a slow inspiratory flow rate improved aerosol 
delivery as compared to a decelerating inspiratory flow pat-
tern with a higher peak inspiratory flow rate [7]. This man-
dates volume-controlled ventilation modality and a deep 
depression of the respiratory drive with sedatives [8]. Con-
versely, reducing sedation is promoted in ICU in order to 
preserve the diaphragmatic function through a spontane-
ous breathing activity and hence to shorten the duration of 
mechanical ventilation [9, 10]. The decelerating inspiratory 
flow pattern and the spontaneous breathing activity of the 
patient (uncontrolled respiratory rate, inspiratory flow rate) 
related to the pressure support modality may affect aerosol 
delivery to the lungs. The comparison of pressure support 
ventilation and volume-controlled ventilation regarding 
aerosol administration has not been investigated.
Recent guidelines focused on the standardization of 
radionuclide imaging methods validated to assess lung 
deposition [11]. Imaging techniques are able to highlight 
the aerosol distribution into the lungs [12]. Twenty years 
ago, scintigraphic studies reported a low aerosol lung 
deposition during invasive mechanical ventilation with a 
jet and ultrasonic nebulizer [13–16]. Since then, pharma-
cokinetic studies showed high concentrations of inhaled 
antibiotics through the lungs after dissection of sub-
pleural lung segments in piglets [17] and after endotra-
cheal suctioning [18] or bronchoalveolar lavage [19, 20] 
in patients suffering from ventilator-associated pneumo-
nia. However, topographic assessment of lung deposition 
by imaging technique during invasive mechanical ventila-
tion has not been investigated.
The aim of this study was to compare in vivo the impact 
of two ventilation modalities, pressure support versus 
volume-controlled ventilation, on lung dose of a radiola-
beled aerosol administered with a vibrating-mesh nebu-
lizer during invasive mechanical ventilation.
Methods
Study design and patient selection
This randomized, comparative, double-blind study 
included postoperative neurosurgery ventilated patients 
with a healthy lung function. Eligibility criteria were 
aged 18  years and older, admitted for brain neurosur-
gery and the availability of krypton gas (81mKr). Patients 
were included if the FEV1 to FVC ratio was superior to 
70  %. Exclusion criteria were spine neurosurgery, his-
tory of cardiovascular and pulmonary disease, extubation 
immediately after surgery, the allocated ventilation mode 
modification during the nebulization and inaccurate 
quantification of aerosol deposition (artifacts or overlap 
of tracheal and pulmonary deposition).
The study protocol was approved by the Institutional 
Medical Ethics Committee (B403201317342). Written 
informed consent was obtained from all participants. 
Preoperative pulmonary function testing was performed 
in the Neurosurgery Department according to the Amer-
ican Thoracic Society guidelines using a MicroLoop 
spirometer (CareFusion, San Diego, CA) [21]. The two 
procedures were randomized by a computer-generated 
random number list. Generation of the random alloca-
tion sequence, enrollment of the patients and allocation 
to the assigned ventilation mode were performed by the 
same clinician author (JD). The double-blind design was 
related to the patients and the data analysis. The nebu-
lizer procedure and image acquisition were performed in 
the same room in the Nuclear Medicine Department.
Invasive mechanical ventilation and nebulization 
procedure
Patients were randomly assigned to pressure support 
(PSV) or volume control (VCV) mode. Patients were ven-
tilated using an ICU turbine-driven ventilator (Bellavista 
1000e, Imtmedical, Buchs, Switzerland) (Fig. 1). Aerosol 
particles were generated continuously by a vibrating-
mesh nebulizer (Aerogen Solo®, provided by Aerogen 
Ltd, Galway, Ireland). The nebulizer was placed between 
the endotracheal tube and the catheter mount because of 
the presence of a proximal flow sensor. The nebulizer res-
ervoir was filled with technetium-99m-labeled diethylen-
etriaminepentaacetic acid (99mTc-DTPA, 2 mCi/3 mL).
The sedative drug (propofol) was titrated in both 
groups to avoid patient’s movements, cough and patient-
ventilator asynchrony during the procedure, while keep-
ing an exclusive spontaneous breathing activity during 
PSV. Patients in VCV did not trigger the ventilator 
based on the absence of spontaneous respiratory rate as 
assessed by continuous observation of the ventilator trac-
ings during the procedure. The ventilatory pattern during 
VCV was: tidal volume of 8 mL/kg and respiratory rate 
targeting a minute ventilation around 8 L/min during the 
postoperative awakening phase. Inspiratory time and res-
piratory rate were then adjusted to ensure an inspiratory/
expiratory ratio of 30 % with a constant inspiratory flow 
of 30 L/min. As there is no end-inspiratory pause in PSV, 
none was imposed in VCV.
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The inspiratory pressure level in PSV was set to reach 
a tidal volume of 8  mL/kg, and the expiratory trigger 
was set to obtain an inspiratory/expiratory ratio of 30 %. 
Positive end-expiratory pressure was set at 5 cmH2O for 
all patients. A bias flow of 10 L/min was imposed by the 
ventilator. Neither heating nor humidification systems 
were used to condition inspired air but a heat and mois-
ture exchanger (HME) filter that was removed during the 
nebulization as suggested previously [8]. A HME filter 
was placed on the expiratory limb during nebulization to 
measure the exhaled dose and to avoid radioactive parti-
cles liberation.
Particle size analysis
Particle size analysis of the radiolabeled aerosol was 
assessed for a decelerating (peak inspiratory flow of 60 L/
min) and a constant inspiratory flow pattern (30 L/min) 
that characterizes the PSV and VCV mode. We used an 
eight-stage Andersen Cascade Impactor (Copley Scien-
tific Ltd, Nottingham, UK) based on pharmacopeia and 
according to the bench model described by Miller et al. 
[22] (Additional file 1). The stage at the median amount 
of radioactivity defined the mass median aerodynamic 
diameter (MMAD).
Image acquisition and deposition analysis
Image acquisitions were performed using a planar sin-
gle detector gamma camera (STARPORT 400 AC/T, GE, 
Hørsholm, Denmark). Nine static anterior acquisitions 
of 2  min were required for counts correction for back-
ground, decay and attenuation and to analyze the pulmo-
nary and extrapulmonary deposition according to recent 
international recommendations (Fig. 2) [23, 24]. Delinea-
tion of lung outlines, regions of interest and counts quan-
tification were performed using the Odyssey program 
(LR Software (v7.0-1.7), Philips).
All data were anonymized by a code number. Data 
analysis was blinded, i.e., performed by a physician of the 
Nuclear Medicine Department without knowledge nei-
ther of the ventilation mode used nor of any particular 
clinical parameters.
Right and left lung deposition was separately measured 
using a rectangular ROI dimensioned on lung outlines 
from the 15 % isocount contour of the 81mKr radioactive 
gas scan [23]. Whole lung deposition was derived from 
the quantification of counts included in these both ROIs. 
Counts correction for background, decay and attenuation 
was performed as described in previous studies [23–25] 
(Additional file  1). A right to the left lung deposition 
Fig. 1 Planar imaging to assess aerosol lung deposition during invasive mechanical ventilation. The ventilator was equipped with a 160‑cm, 22‑mm 
inner‑diameter ventilator circuit (IMMED, Bruxelles, Belgium) including a 7‑cm proximal flow sensor (PFS, Hamilton Medical, Bonaduz, Switzerland) 
positioned between the Y‑piece and the catheter mount, a protection filter and the vibrating‑mesh nebulizer. The patient was in semirecumbent 
position at 15° with the head turned right to avoid the overlap of the thorax, the ventilator circuit and the gamma camera (at 10 cm of the sternum)
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ratio was calculated to compare both lung depositions. A 
penetration index defined the penetration of aerosol par-
ticles from an inner to an outer rectangular lung region 
designed from the 81mKr ventilation scan and reported 
on the 99mTc-DTPA scan. The penetration index was 
calculated as the outer to inner lung region ratio (O/I) 
from the 99mTc-DTPA acquisition normalized to the O/I 
ratio from the 81mKr gas acquisition as described previ-
ously [23]. Extrapulmonary deposition was determined 
by the total count measured in the nebulizer reservoir 
minus whole lung count. Deposition analysis within the 
endotracheal tube and the trachea was determined by the 
Fig. 2 Summary of the protocol
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total extrapulmonary deposition minus the total count in 
the ventilator circuit and retained in the expiratory filter 
and the nebulizer reservoir. It was grouped due to the dif-
ficult differentiation of the deposition in the distal part 
of the endotracheal tube and the trachea. Radiolabeled 
deposition on each component of the ventilator circuit 
and the expiratory filter was quantified using a ROI fitted 
to their size. According to the ventilator circuit, the term 
“proximal” was used when the pieces were close to the 
patient, i.e., the proximal flow sensor, the catheter mount 
and the nebulizer T-piece.
Pulmonary deposition and extrapulmonary deposition 
of radiolabeled particles were expressed in counts and 
as a percentage of the nominal dose (i.e., the amount of 
radioactivity placed in the nebulizer at the beginning of 
experiments).
Statistical analysis
Statistical analysis was performed using SPSS software 
(version 20.0, IBM software). Sample size calculation was 
based on a 7  % expected difference in mean deposition 
for a statistical power of 80 % [3, 26]. Data are expressed 
as mean ± standard deviation (SD) or median (25–75 % 
interquartile range (IQR)) depending on the normality 
tested using the Kolmogorov–Smirnov test. Compari-
son of both ventilation modes was conducted with inde-
pendent Student t tests or Mann–Whitney test. Both 
lungs were compared using a Wilcoxon test for paired 
organs. Correlation between aerosol lung deposition and 
the ventilatory pattern was conducted using the Pearson 
correlation coefficient (r). The intersubject variability of 
whole lung deposition was determined by the calculation 
of the coefficient of variation (CV). A p value lower than 
0.05 was considered significant.
Results
Two hundred thirty-eight patients schedule for postoper-
ative ICU admission were screened for eligibility between 
July 2013 and June 2015 (completion date according 
to the sample size calculation). Among nineteen ran-
domized patients, two patients allocated to PSV were 
excluded. One patient was excluded because mandatory 
sedation during the procedure implied to switch from 
PSV to pressure-controlled ventilation. The other patient 
was excluded because quantification of aerosol lung 
deposition was impossible due to technical reasons. The 
study included seventeen postoperative neurosurgery 
ventilated patients, eight in PSV and nine in VCV (Fig. 2). 
Patient characteristics are depicted in Table 1.
Nebulization lasted on average 9 ± 3 min. The dynamic 
acquisition revealed a linear increase in counts in lung 
ROI that confirmed the absence of clearance of the 
aerosol during nebulization. The absence of potential 
radioactivity quantified on the expiratory valve of the 
ventilator ensured the effective retention of exhaled par-
ticles in the HME filter. No ambient and surface contami-
nation was detected after the procedure.
The MMAD at the distal tip of the endotracheal tube 
was 2.1  ±  0.07 and 1.95  ±  0.37  µm with a constant 
inspiratory flow pattern of 30  L/min and a decelerating 
inspiratory flow pattern with a peak inspiratory flow of 
60  L/min, respectively. Mechanical ventilation settings 
and ventilatory pattern during inhalation are presented 
in Table 2. A similar inspiratory time was observed with 
both ventilation modes. The decelerating inspiratory flow 
pattern during PSV resulted in a higher inspiratory flow 
rate. Patients had a lower respiratory rate during PSV, 
resulting in a longer expiratory time.
Pulmonary and extrapulmonary deposition and the 
penetration index according to both ventilation modes 
are detailed in Table 3. The attenuation correction factor 
was 1.65 ± 0.19 and 1.56 ± 0.18 in PSV and VCV, respec-
tively. The deposited drug amount into the lungs was sig-
nificantly higher during VCV (p = 0.038), while a higher 
aerosol deposition on the endotracheal tube, the trachea 
and main bronchi was observed during PSV (p = 0.043). 
We observed a similar aerosol deposition between both 
ventilation modes in each lung analyzed separately 
(p = 0.057 and p = 0.885 for the right and the left lung, 
respectively). The penetration index was also comparable 
Table 1 Patient characteristics
Quantitative variables are expressed as mean ± SD. Qualitative variables are 
expressed as a proportion (%)
FEV1 forced expiratory volume in 1 s, FVC forced vital capacity
PSV (n = 8) VCV (n = 9) p value
Age (years) 56 ± 8 61 ± 11 0.254
Male, n (%) 5 (62.5) 4 (44.4)
Height (cm) 169 ± 10 165 ± 11 0.441
Body weight (kg) 74 ± 14 68 ± 21 0.431
Ideal body weight (kg) 65 ± 10 59 ± 10 0.516
Smoker, n (%) 3 (37.5) 3 (33.3)
Surgery, n (%)
 Brain tumor resection 3 (37.5) 2 (22.2)
 Embolization of intracranial 
unruptured aneurysm
3 (37.5) 0
 Neurosurgical clipping of a 
unruptured intracranial aneu‑
rysms
1 (12.5) 6 (66.7)
 Stereotactic brain biopsy 1 (12.5) 0
 Vestibular schwannoma resection 0 1 (11.1)
Lung function
 FEV1 (% predicted value) 95 ± 16 97 ± 9 0.777
 FVC (% predicted value) 100 ± 19 101 ± 14 0.927
 FEV1/FVC 77 ± 5 79 ± 6 0.509
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between both modes for the right (p = 0.210) and the left 
lung (p = 0.211).
If we compare aerosol deposition between both lungs, 
there was no significant difference of deposition between 
the right and the left lung (p  =  0.093 and p  =  0.066 
during PSV and VCV, respectively). The penetration 
index of the right and the left lung was comparable dur-
ing PSV (p = 1.000) and during VCV (p = 0.066).
Pulmonary aerosol deposition was highly variable 
among patients with a coefficient of variation of 28 % and 
33 % during PSV and VCV, respectively. A high variabil-
ity of the penetration index and the right to the left lung 
deposition ratio was also found with the two ventilation 
modes (Fig. 3a, b). Intersubject variability of aerosol lung 
deposition whatever the ventilation mode is illustrated in 
Fig. 3c.
No correlation between lung deposition and the inspir-
atory flow rate was found for the two modes. However, 
lung deposition was correlated with the respiratory rate 
(r = 0.741, p = 0.036) and inversely correlated with the 
expiratory time (r = −0.846, p = 0.008) during PSV.
Extrapulmonary aerosol deposition was higher dur-
ing PSV (p =  0.038) due to a higher deposition on the 
endotracheal tube, the trachea and main bronchi. A simi-
lar aerosol deposition on the ventilator circuit (p = 0.486) 
and the expiratory filter (p =  0.710) was observed with 
both ventilation modes. Around 3 % of the nominal dose 
was retained on the nebulizer reservoir at the end of 
nebulization.
Discussion
This study showed that volume-controlled ventilation 
increased aerosol delivery to the lungs as compared to 
pressure support ventilation with a vibrating-mesh nebu-
lizer connected to the endotracheal tube. Lung dose and 
the site of deposition were highly variable among patients 
with both ventilation modes.
This study demonstrated better aerosol delivery to the 
lungs (between 10.5 and 15.1  % of the nominal dose) 
through an endotracheal tube as compared to previous 
scintigraphic studies (2.1–5.3  % of the nominal dose) 
[13, 14, 16]. High residual volume retained in the reser-
voir (29.6–51.5  % of the nominal dose) of their jet and 
ultrasonic nebulizers, delayed actuation of their breath-
actuated jet nebulizer and deposition analysis performed 
on patients with respiratory failure (ARDS, COPD, neu-
romuscular disorders, open-heart surgery) were factors 
pointed out by previous authors that affected lung deliv-
ery and hence explain this discrepancy [13, 14, 16].
Lung deposition of 15  % reported during volume-
controlled ventilation is consistent with the amount 
of amikacin measured in  vitro at the distal tip of the 
endotracheal tube using the same nebulizer position and 
ventilatory settings [7]. However, lung deposition is still 
low in comparison with other studies using breath-actu-
ated jet nebulizers (15.3 ± 9.5 % of radiotracer deposited 
in the lungs) [15], continuous vibrating-mesh nebulizers 
Table 2 Mechanical ventilation details and  ventilatory 
pattern during inhalation
Data expressed as mean ± SD or median (25–75 % IQR)
P-value in italic is considered significant (p < 0.05)
ETT endotracheal tube, MV minute ventilation, P pressure, RR respiratory rate, 
Tinsp inspiratory time, TinspTTot inspiratory time to breathing cycle time ratio, Texp 
expiratory time, VT tidal volume
PSV (n = 8) VCV (n = 9) p value
Sedatives (propofol, mg/h) 190 (160–252) 200 (160–260) 0.622
ETT diameter (mm) 8.0 (7.5–9.0) 7.0 (7.5–8.5) 0.252
81mKr ventilation distribution
 Right/left lung ratio 1.13 ± 0.25 1.09 ± 0.32 0.755
Ventilatory pattern during inhalation
 Ppeak (cmH2O) 16 ± 3 20 ± 1 0.005
 VT insp (mL) 586 ± 117 530 ± 95 0.292
 VT insp (mL/kg IBW) 8.65 (8.00–8.90) 8.70 (8.55–9.20) 0.439
 RR (cycle/min) 14 ± 1 18 ± 2 <0.001
 MVinsp (L/min) 8.01 ± 1.48 9.17 ± 0.92 0.070
 Flowpeak insp (L/min) 44 ± 8 32 ± 4 0.002
 Tinsp (s) 1.15 ± 0.19 1.12 ± 0.12 0.664
 Texp (s) 3.72 (2.91–3.99) 2.24 (2.16–2.55) 0.001
 TinspTTot (%) 25 (22–34) 32 (32, 33) 0.072
Table 3 Aerosol deposition in  seventeen postoperative 
neurological patients
Data expressed as mean ± SD (coefficient of variation, %) or median (25–75 % 
IQR). Proximal pieces of the ventilator circuit included the catheter mount, the 
nebulizer T-piece and the proximal flow sensor
P-value in italic is considered significant (p < 0.05)
ETT endotracheal tube
PSV (n = 8) VCV (n = 9) p value
Pulmonary deposition (%) 10.5 ± 3.0 (28) 15.1 ± 5.0 (33) 0.038
Right lung 6.1 ± 1.9 (31) 10.6 ± 5.8 (55) 0.057
 Penetration index 0.75 (0.30–0.94) 0.32 (0.16–0.77) 0.210
Left lung 4.1 (3.8–4.6) 4.5 (2.2–5.6) 0.885
 Penetration index 0.67 (0.53–0.86) 0.74 (0.6–1.06) 0.211
Right/left lung ratio 1.39 (0.91–2.05) 3.33 (0.7–5.38) 0.336
Extrapulmonary deposition 
(%)
89.5 ± 3.0 84.9 ± 5.0 0.038
ETT and tracheal area 27.4 ± 6.6 (24) 20.7 ± 6.0 (29) 0.043
Expiratory filter 23.7 ± 5.3 (22) 22.5 ± 7.6 (34) 0.710
Ventilator circuit 34.7 ± 8.7 (25) 38.4 ± 12.3 (32) 0.486
  Proximal pieces 32.0 ± 7.4 (23) 35.9 ± 12.5 (35) 0.451
  Insp–expi tubing 2.7 ± 1.9 (70) 2.5 ± 1.7 (68) 0.833
Nebulizer retention 3.7 ± 0.9 (24) 3.3 ± 0.7 (21) 0.334
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(40–60  % of antibiotics deposited in piglets lungs) [26, 
27] and a recent breath-actuated vibrating-mesh nebu-
lizer connected to the endotracheal tube (72 ±  11  % of 
aerosol delivery to a lung model) [20]. The explanation 
is the nebulizer configuration used in the present study, 
i.e., connected to the endotracheal tube for a continuous 
nebulization. It led to a significant aerosol loss during the 
expiratory time [5]. A more distal position was used in 
other studies using continuous nebulization (from 30 cm 
of the Y-piece to the inspiratory inlet of the ventilator) 
[3, 27]. At the time of the study, the proximal flow sen-
sor was considered as a potential barrier for nebulized 
Fig. 3 High intersubject variability of aerosol penetration through the lungs and its deposition between the right and the left lung during pressure 
support ventilation and volume‑controlled ventilation. a A penetration index equal to 1 indicated a linear aerosol penetration from the inner to 
the outer part of the lungs. Particles deposition was limited to the central airways with both ventilation modes. b A right/left lung deposition ratio 
equal to 1 indicated a similar aerosol deposition in both lungs. Right lung deposition was predominant with both ventilation modes, especially 
during volume‑controlled ventilation. c Scintigraphic images of aerosol lung deposition in two patients in volume‑controlled ventilation (left) and 
two patients in pressure support ventilation (right). With both ventilation modes, the first patient on the left benefits of a symmetrical aerosol lung 
deposition while a predominant left lung or right lung deposition is depicted in the patient on the right. Aerosol penetration from the inner to the 
outer lung region varies also among patients
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particles, implying to position the nebulizer after this 
sensor just before the endotracheal tube. However, 
we showed recently that the proximal flow sensor has 
no impact when the nebulizer is placed at 45 cm of the 
Y-piece or connected to the inspiratory inlet of the venti-
lator whatever the inspiratory flow pattern (decelerating 
or constant) [7]. Both positions could have led to a better 
aerosol delivery with both ventilation modes and should 
be assessed in further in vivo studies.
Many factors may explain the lower lung deposition 
during pressure support. The lower respiratory rate 
(while keeping a similar inspiratory time and tidal vol-
ume) during pressure support led to a decrease in lung 
deposition as compared to volume control. Reducing the 
respiratory rate without increasing neither the inspira-
tory time nor the tidal volume led to an increase in the 
expiratory time and hence reduced aerosol delivery distal 
to the endotracheal tube during continuous nebulization 
[28]. Aerosol lung deposition normalized to the respira-
tory rate becomes similar to the two modes (p = 0.378). 
The low respiratory rate in pressure support was due to 
the minimal sedation mandatory to the safe postopera-
tive management of neurosurgery patients. Less patient 
sedation may lead to a higher respiratory rate and hence 
better lung deposition during pressure support providing 
that there is no increase of the inspiratory flow rate.
The higher inspiratory flow rate during pressure sup-
port ventilation could also explain the lower lung deposi-
tion with this mode. It is well known that the higher the 
inspiratory flow rate, the lower the lung deposition of 
aerosolized particles [29, 30]. However, lung deposition 
was independent of the inspiratory flow rate variation 
between the two modes tested in this study.
The aerosol penetration from the inner to the outer 
part of the lungs was similar to the two modes. One 
major factor that influences aerosol penetration is the 
particle size [31]. A comparable MMAD around 2  µm 
distal to the endotracheal tube was obtained whatever 
the inspiratory flow pattern.
As reported by Thomas et  al. [16], we found a pen-
etration index around 0.5 for both lungs. A penetration 
index below 1 indicates a more central deposition of 
aerosol [32, 33]. Poor aerosol penetration during invasive 
mechanical ventilation could be explained by particles 
impaction and trickling from the endotracheal tube to 
the trachea and main bronchi [14, 16, 34].
The high intersubject variability of the aerosol lung 
dose, lung penetration and the heterogeneous regional 
distribution whatever the ventilation mode in patients 
with healthy lungs is the major finding of this study. We 
expected that the uncontrolled ventilatory pattern dur-
ing pressure support ventilation would induce a higher 
variability of aerosol lung deposition. Surprisingly, a 
higher variability of lung dose and lung penetration was 
observed during volume-controlled ventilation as com-
pared to pressure support ventilation.
The lung anatomy and the potential postoperative con-
cerns (retention of bronchial secretions, minor atelec-
tasis) more likely explain this high variability [35]. The 
relatively small variability of the nebulizer output (5  %) 
[6] and images quantification performed by two blind cli-
nicians ensured the accuracy and the reproducibility of 
the analysis.
The aerosol distribution between both lungs was also 
variable among patients although a majority presented a 
higher aerosol deposition in the right lung. Two studies 
also found a higher aerosol delivery in the right lung of 
intubated patients following open-heart surgery [14, 16]. 
Our patients had healthy lungs unaffected by the surgical 
procedure. Repartition of the ventilation in the right/left 
lung depicted by the 81mKr ventilation scan was close to 
55/45 % indicating a normally distributed ventilation vol-
ume [36]. The increased right lung deposition could be 
explained by this physiological increased right lung ven-
tilation [37]. The fact that the patient’s head was turned 
right for all patients may also explain the predominant 
right lung deposition because of an uncontrolled twist 
of the endotracheal tube. This had no effect on a volume 
tracer such as 81mKr, but lead to more proximal bronchus 
deposition on the right side. As shown in Fig. 3b, c, this 
effect is rather versatile.
High aerosol impaction on the endotracheal tube and 
the trachea (20–27 % of the nominal dose) was measured 
with both modes. Larger particles which were generated 
at the inlet of the endotracheal tube directly impacted the 
lumen of the endotracheal tube. Higher impaction during 
pressure support is explained by the higher inspiratory 
flow rate inherent to this ventilation mode. Previous scin-
tigraphic studies reported a comparable aerosol deposi-
tion within the ventilator circuit around 30 % [13, 14, 16]. 
However, we found a majority of aerosolized particles 
deposited on the proximal pieces of the ventilator circuit 
(proximal flow sensor, the catheter mount and the nebu-
lizer T-piece).The expiratory filter captured around 20 % 
of aerosolized particles. Our nebulizer generated parti-
cles proximally during the entire breathing cycle. Parti-
cles were captured on proximal pieces of the ventilator 
circuit or directly lost on the expiratory limb during the 
long expiratory time measured in this study [7, 38].
Our study has several limitations. First, extrapolation of 
our results is limited due to the nebulization performed 
in patients with healthy lungs, using a radiotracer instead 
of a relevant drug, using a minimal mandatory sedation 
during pressure support ventilation and a ventilator cir-
cuit without heated and humidifier system. However, the 
aim of the study was to focus on the effect of mechanical 
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ventilation on nebulization efficiency and not on its clini-
cal benefit. Second, the continuous nebulizer was con-
nected to the endotracheal tube. At the beginning of the 
study, the distal position was not known as the optimal 
position to reduce aerosol loss considering the presence 
of the proximal flow sensor on the ventilator circuit [7]. 
Further clinical study with nebulizer positioned at 30, 
45  cm above the Y-piece or at the inspiratory outlet of 
the ventilator is required. Third, quantification was per-
formed based on counts derived from a single anterior 
planar image instead of a geometric mean of anterior 
and posterior counts that could decrease the accuracy of 
the quantification [23]. Safety concern imposed to avoid 
patient’s transfer to the examination table and posterior 
images of the lungs could not be acquired due to bed 
structure; this bias, if of any relevance, was, however, 
constant for all patients in both groups.
In conclusion, volume-controlled ventilation was 
associated with higher aerosol delivery to the lungs as 
compared to pressure support ventilation with a vibrat-
ing-mesh nebulizer connected to the endotracheal tube 
in the specific conditions of the study. Lung deposition 
during pressure support ventilation was nonetheless 
substantial and should be further assessed using lighter 
sedation. Aerosol therapy is totally unpredictable in term 
to the location of aerosol deposition through the lungs. 
A high intersubject variability of lung doses, particles 
penetration and distribution between both lungs was 
demonstrated with the two ventilation modes. Before 
promoting volume control mode to administer an aerosol 
during invasive mechanical ventilation, we should assess 
the clinical benefit of the average 50 % differences in lung 
deposition in patients with a need for aerosol therapy 
such as inhaled antibiotics.
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